18F-Labelled compounds as active substances of radiopharmaceuticals are used for imaging in positron emission tomography (PET) in nuclear medicine. The radiosynthesis of PET radiopharmaceuticals is based on nucleophilic substitution with F- in a precursor. The synthesis is demonstrated on 3?-deoxy-3?-[18F]fluorothymidine.